TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Functional Ambulation Category
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cardiovascular events (CVE)
Endpoint domain: Mortality/survival
Primary endpoint: Change in diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduced occurrence of genital ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reduced occurrence of erythema nodosum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reduced occurrence of arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: functional independence (mRS 0-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: follow-up infarct volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversal of MHE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Development of overt HE
Endpoint domain: Adverse events/effects
Primary endpoint: Union rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adverse events (e.g., infections, need for plate removal)
Endpoint domain: Adverse events/effects
Primary endpoint: SV (Stroke Volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful extubation after weaning trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monocular visual acuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular visual acuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference between adult and pediatric IKDC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deficit in QF vastii volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deficit in QF maximal isometric torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: rates of progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean visual analog scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vulvar scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety about cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived importance of breast cancer as a health issue
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: learning from educational materials
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: QoR-15 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: gains in L1 and L2 vocabulary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body fat increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain due to propofol injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased participation in physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early biofilm formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Fractions of antigen-primed, activated memory B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mobilization performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fit to discharge
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: mean scores for cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean scores for sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of transfusion risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived dread of transfusion risk
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of transfusion risk perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: average 5-m and 15-m sprint times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery CMJT performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDV increase to predict infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LANSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional blunting score dimension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of care (PACIC scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of adverse cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: left ventricular remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual analog pain scale (VAPS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean s-IgA titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Upper limb blood flow increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Alcoholic beverage consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported screening for breast cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidents of bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Moderate or severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Urinary Albumin Excretion (UAE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversal to normoalbuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 24-hour Ambulatory Blood Pressure (AMBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median time to discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost of anaesthesia
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfactory anaesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal resistance factor (CRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal hysteresis (CH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal flattening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma exposure to unmetabolized drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean error frequency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ablation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of char and coagulum formation
Endpoint domain: Adverse events/effects
Primary endpoint: 1-year postoperative survival rate
Endpoint domain: Mortality/survival
Primary endpoint: 3-year postoperative survival rate
Endpoint domain: Mortality/survival
Primary endpoint: anal preservation rate
Endpoint domain: Physiological/clinical
Primary endpoint: PEFR (Peak Expiratory Flow Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: time to brain progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mortality within 14 days
Endpoint domain: Mortality/survival
Primary endpoint: Vital status at six months
Endpoint domain: Mortality/survival
Primary endpoint: Probability of not falling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion (ROM) subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief in female patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relief in patients aged 60 years or older
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RTW‐SE scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite of cardiac death and hospitalization for worsening heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Cure rate for bacterial vaginosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement on CAM assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of CAM assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: FEV1AUC0‐24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: >15% increase in inspiratory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement on the ESMS
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement on the Information subscale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement on the Energy/Fatigue of the QOLIE‐31
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: homologous blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Disease Activity Score in 28 joints (DAS28-CRP) of <3.2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Activity Score in 28 joints (DAS28-CRP) of <2.6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-emergent adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of additional rescue analgesic administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily activity performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vaginal bleeding/spotting rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Concentration at loss of the eyelash reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Collagen type I/III ratio in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collagen type I/III ratio in aponeurosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collagen type I level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain threshold scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain tolerance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menarche incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triceps skinfold thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Normalized methionine loading test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of preeclampsia
Endpoint domain: Adverse events/effects
Primary endpoint: Severe hypoglycemia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fungal Free Survival (FFS)
Endpoint domain: Mortality/survival
Primary endpoint: exercise FBF increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FVC increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of motor and sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total days in the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Recovery of daily activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long term complications
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of inflammatory parameters (ADN and TNF-alpha)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flow‐mediated dilator response to hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma high‐sensitivity C‐reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of heavy menstrual bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iodine concentration in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Estimated 24-hour iodine excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total iodine intake (diet plus supplements)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of PUBs
Endpoint domain: Adverse events/effects
Primary endpoint: Overall success of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in core set variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic exposure of rhACE2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ang1‐8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of rhACE2
Endpoint domain: Adverse events/effects
Primary endpoint: Anastomosis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of difficulty with ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medication continuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of appropriate referrals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median testing rate for H pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall expenditure on acid‐suppressing drugs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement of 50% or more in symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of postoperative stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall physician satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chart quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Chart accuracy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: No-call rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discordant-call rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor and cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: DM diet educational skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DM diet knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of aminotransferase, total bilirubin, direct bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: PT and total serum protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Drug consumption scores
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Allergen-specific nasal reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: reduction in gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pelvic regional recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Distant metastasis
Endpoint domain: Mortality/survival
Primary endpoint: subjective sensation of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Semaglutide pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent organ failure incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day death or MI
Endpoint domain: Mortality/survival
Primary endpoint: Recovery from CIP/CIM
Endpoint domain: Mortality/survival
Primary endpoint: Electrophysiological signs of CIP and/or CIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: death or serious outcomes in the infant
Endpoint domain: Mortality/survival
Primary endpoint: having an infant with a birth weight below the 10th percentile for gestational age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: post-operative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activated protein C resistance ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ovarian reserve assessed by AMH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maintenance rate of target Hb levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maintenance rate of ferritin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Duration of menstrual pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of radiation sialadenitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of stomatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of impotence
Endpoint domain: Adverse events/effects
Primary endpoint: Physical functioning
Endpoint domain: Mortality/survival
Primary endpoint: median logins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRT use at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decline in cognitive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak FBF response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total reactive hyperemic flow (FDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in C. albicans counts in saliva, lesions, and dentures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Need for periodontal surgery or extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Relapse of hypomanic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in intraocular pressure (IOP) after ocular compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight and length gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PINP SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-year cardiac mortality
Endpoint domain: Mortality/survival
Primary endpoint: One-year incidence of definite and/or probable ST
Endpoint domain: Mortality/survival
Primary endpoint: Discontinuation due to constipation
Endpoint domain: Adverse events/effects
Primary endpoint: RVNA titers > or =0.5 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: disease-specific cumulative survival rates
Endpoint domain: Mortality/survival